Terms: = Liver cancer AND ETV5, P41161, 2119, ENSG00000244405, ERM AND Prognosis
6 results:
1. Inhibition of TRPV4 remodels single cell polarity and suppresses the metastasis of hepatocellular carcinoma.
Liu J; Guo Y; Zhang R; Xu Y; Luo C; Wang R; Xu S; Wei L
Cell Death Dis; 2023 Jun; 14(6):379. PubMed ID: 37369706
[TBL] [Abstract] [Full Text] [Related]
2. Clinicopathological Features and prognosis of Gastrointestinal Metastases From Breast Carcinoma: A Clinicopathological Study of 22 Patients.
Wang S; Li W; Li S; Liu X; Zhang L; Hao C; Meng W; Zhao W; Tong Z
Int J Surg Pathol; 2023 Sep; 31(6):1075-1084. PubMed ID: 36803140
[No Abstract] [Full Text] [Related]
3. Ezrin promotes hepatocellular carcinoma progression by modulating glycolytic reprogramming.
Wang X; Li N; Han A; Wang Y; Lin Z; Yang Y
Cancer Sci; 2020 Nov; 111(11):4061-4074. PubMed ID: 32639665
[TBL] [Abstract] [Full Text] [Related]
4. Establishment of a Nomogram by Integrating Molecular Markers and Tumor-Node-Metastasis Staging System for Predicting the prognosis of Hepatocellular Carcinoma.
Huang XT; Chen LH; Huang CS; Li JH; Cai JP; Chen W; Yin XY
Dig Surg; 2019; 36(5):426-432. PubMed ID: 30481744
[TBL] [Abstract] [Full Text] [Related]
5. A splicing variant of Merlin promotes metastasis in hepatocellular carcinoma.
Luo ZL; Cheng SQ; Shi J; Zhang HL; Zhang CZ; Chen HY; Qiu BJ; Tang L; Hu CL; Wang HY; Li Z
Nat Commun; 2015 Oct; 6():8457. PubMed ID: 26443326
[TBL] [Abstract] [Full Text] [Related]
6. Ezrin expression is an independent prognostic factor in gastro-intestinal cancers.
Arumugam P; Partelli S; Coleman SJ; Cataldo I; Beghelli S; Bassi C; Wijesuriya N; Aleong JA; Froeling FE; Scarpa A; Kocher HM
J Gastrointest Surg; 2013 Dec; 17(12):2082-91. PubMed ID: 24155054
[TBL] [Abstract] [Full Text] [Related]
